Á lódáil...
5PSQ-003 Effectiveness and safety of vedolizumab in ulcerative colitis and crohn’s disease
BACKGROUND: Vedolizumab is a monoclonal antibody for the treatment of ulcerative colitis and Crohn’s disease. PURPOSE: The aim of this study was to determine the effectiveness and safety of vedolizumab in our hospital since its inclusion in the pharmaceutical guide in April 2016 to the current date...
Na minha lista:
| Foilsithe in: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BMJ Group
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535328/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.357 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|